Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 122, 2002 - Issue 8
Submit an article Journal homepage
23
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Presence of Platelet-activating Factor in Nasal Polyps and Eosinophils

Masayuki Furukawa Department of Otolaryngology, Kansai Medical University, Osaka, Japan
,
Manabu Ogura Department of Otolaryngology, Kansai Medical University, Osaka, Japan
,
Toshiyuki Tsutsumi Department of Otolaryngology, Kansai Medical University, Osaka, Japan
,
Hiroyuki Tsuji Department of Otolaryngology, Kansai Medical University, Osaka, Japan
&
Toshio Yamashita Department of Otolaryngology, Kansai Medical University, Osaka, Japan
Pages 872-876 | Published online: 08 Jul 2009

  • Bernstein JM. Role of allergy in nasal polyposis: a review. Otolaryngol Head Neck Surg 1995; 113: 72432.
  • Jankowski R. Eosinophils in the pathophysiology of nasal polyposis. Acta Otolaryngol (Stockh) 1996; 116: 160-3.
  • Furukawa M, Horii T, Oda M, Satouchi K, Saito K. PAF in human respiratory diseases. J Lipid Mediat 1992; 5: 191-2.
  • Prescott SM, Zimmerman GA, Mclntyre TM. Plateletactivating factor. J Biol Chem 1990; 295: 17381-4.
  • Furukawa M, Yamashita T, Kumazawa T, Satouchi K, Saito K. Evidence of platelet-activating factor in nasal polyps. ORL J Otorhinolaryngol Relat Spec 1992; 54: 29-32.
  • Stoop AE, Harry A, van der Heijden JB, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91: 616-22.
  • Zoratti EM, Sedgwick JB, Vrtis RR, Busse WW. The effect of platelet-activating factor on the generation of Superoxide anion in human eosinophils and neutrophils. J Allergy Clin Immunol 1991; 88: 749-58.
  • Weller PF, Bozza PT, Yu W, Dvorak AM. Cytoplasmic lipid bodies in eosinophik central roles in eicosanoid generation. Allergology Int 1997; 46: 141-53.
  • Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic for human eosinophik J Clin Invest 1986; 78: 1701-6.
  • Terashita Z, Tsushima S, Yoshioka Y, Nomura H, Inada Y, Nishikawa K. CV-3988 a specific antagonist of platelet-activating factor (PAF). Life Sei 1983; 32: 1975-82.
  • Hwang S-B, Lam M-H, Bftu T, Beattie TR, Shen T-Y. Trans-2,5-bis-(3,4,5-trimethoxypheny1) tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet-activating factor. J Biol Chem 1985; 260: 15639-45.
  • Furukawa M, Kubo N, Yamashita T. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. Laryngoscope 1995; 105: 188-91.
  • Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Physiol 1959; 37: 911-7.
  • Bartlett GR. Phosphorous assay in chromatography. J Biol Chem 1959; 234: 466-8.
  • Pinckkard RN, Farr RS, Hanahan DJ. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol 1979; 123: 1847-57.
  • Oda M, Satouchi K, Yasunaga K, Satouchi K. PoIymorphonuclear leukocyte-platelet interactions: acetylglyceryl ester phosphocholine-induced platelet activation under stimulation with chemotactic peptide. J Biochem (Tokyo) 1986; 100: 1117-23.
  • Nakagawa N, Obata T, Kobayashi T, et al. Effect of peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma. Eur J Pharmacol 1993; 265: 211-9.
  • Jung TTK, Juhn SK, Hwang D, Stewart R. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987; 97: 184-9.
  • Kaliner M, Wasserman SL, Austen KF. Immunologie release of chemical mediators from human nasal polyps. N Engl J Med 1973; 289: 277-81.
  • Inoue H, Ganbo T, Hisamitsu K, Ishida H. Study on the metabolism of lyso-platelet activating factor (lysoPAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF. Life Sei 1993; 52: 227-32.
  • Yamashita T, Tsuji H, Maeda N, Tomoda K, Kumazawa T. Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinology 1989; 8 (Suppl): 15-24.
  • Ogata N, Masayama K, Yoshida M, et al. Evidence for interleukin-5 in nasal polyp in aspirin-induced asthma. Allergology Int 1997; 46: 161-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.